Skip to search.
 All Ordinaries Down 0.78%

More On ACL.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Alchemia Ltd (ACL.AX)

-ASX
0.01 Up 0.00(18.18%) 24 Feb 14:37
Prev Close:0.01
Open:0.01
Bid:0.01
Ask:0.01
1y Target Est:N/A
Beta:-4.17917
Next Earnings Date:N/A
Day's Range:0.01 - 0.01
52wk Range:0.01 - 0.02
Volume:220,015
Avg Vol (3m):214,397
Market Cap:4.22M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-17) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alchemia Limited, a biopharmaceutical company, engages in developing oncology products. It provides Fondaparinux sodium, a generic anti-coagulant drug. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback